Emergent BioSolutions CEO Robert Kramer's 2019 pay jumps 54% to $3.7M
Emergent BioSolutions reports 2019 executive compensation
By ExecPay News
Published: April 9, 2020
Emergent BioSolutions reported fiscal year 2019 executive compensation information on April 9, 2020.
In 2019, six executives at Emergent BioSolutions received on average a compensation package of $2.2M, a 10% decrease compared to previous year.
Average pay of disclosed executives at Emergent BioSolutions
Robert G. Kramer, Chief Executive Officer, received $3.7M in total, which increased by 54% compared to 2018. 39% of Kramer's compensation, or $1.4M, was in stock awards. Kramer also received $557K in non-equity incentive plan, $1M in option awards, $678K in salary, as well as $5.7K in other compensation.
Fuad El-Hibri, Chairman, received a compensation package of $3M, which increased by 1% compared to previous year. 38% of the compensation package, or $1.1M, was in salary.
Richard S. Lindahl, Chief Financial Officer, earned $1.9M in 2019, a 16% increase compared to previous year.
Atul Saran, General Counsel, received $1.9M in 2019, which increases by 10% compared to 2018.
Adam Havey, Executive Vice President, Business Operations, earned $1.8M in 2019, a 11% increase compared to previous year.
Daniel J. Abdun-Nabi, Chief Executive Officer, received $633K in 2019, which decreases by 85% compared to 2018.
Related executives
Fuad El-Hibri
Emergent BioSolutions
Chairman
Robert Kramer
Emergent BioSolutions
Chief Executive Officer
Richard Lindahl
Emergent BioSolutions
Chief Financial Officer
Adam Havey
Emergent BioSolutions
Executive Vice President, Business Operations
Atul Saran
Emergent BioSolutions
General Counsel
Daniel Abdun-Nabi
Emergent BioSolutions
Chief Executive Officer
You may also like
Source: SEC filing on April 9, 2020.